Aberrant Nuclear/Cytoplasmic Localization and Gene Mutation of β-Catenin in Classic Pulmonary Blastoma
- 1 July 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Surgical Pathology
- Vol. 28 (7), 921-927
- https://doi.org/10.1097/00000478-200407000-00012
Abstract
It is now known that gene mutation of beta-catenin with subsequent nuclear/cytoplasmic (N/C) overaccumulation of the protein plays an important role in tumorigenesis of various organs. We recently demonstrated that low-grade adenocarcinoma of the fetal lung type (L-FLAC)/well-differentiated fetal adenocarcinoma (WDFA), the epithelial prototype of classic pulmonary blastoma (CPB), shows N/C localization of beta-catenin with genetic mutation. This prompted us to further investigate the state of beta-catenin abnormality in CPB and related neoplasms. We studied 9 lung tumors previously diagnosed as biphasic pulmonary blastoma (PB). Histologically, 4 cases (median age 34 years) were CPB with l-FLAC/WDFA as the epithelial component, whereas 5 cases (median age 65 years) were a variant of carcinosarcoma with high-grade FLAC/clear cell adenocarcinoma with fetal lung features as the epithelial component, which we term the blastomatoid variant of carcinosarcoma (BCS). Immunohistochemically, all 4 CPBs showed aberrant N/C localization of beta-catenin both in the epithelial and mesenchymal components, with especially high staining intensity in the budding glands and morules. In contrast, all 5 BCSs showed preserved or diminished membranous expression and no significant N/C expression of beta-catenin in the epithelial component, and absent or focal N/C expression of beta-catenin in the mesenchymal component. Mutational analysis of exon 3 of the beta-catenin gene revealed that 3 CPBs harbored missense mutations (S29F, S37F, and S37F), whereas none of the 5 BCSs had this mutation. This study suggests that beta-catenin gene mutations may play a role in the tumorigenesis of CPB. Although CPB and BCS have often been grouped together as biphasic PB, they are different entities based on immunohistochemical and molecular analysis of beta-catenin. Immunostaining for beta-catenin is useful for the discrimination.Keywords
This publication has 27 references indexed in Scilit:
- Aberrant Intranuclear Localization of Biotin, Biotin-binding Enzymes, and β-Catenin in Pregnancy-Related Endometrium and Morule-Associated Neoplastic LesionsLaboratory Investigation, 2003
- β‐Catenin mutations in pulmonary blastomas: association with morule formationThe Journal of Pathology, 2003
- Apc modulates embryonic stem-cell differentiation by controlling the dosage of β-catenin signalingNature Genetics, 2002
- Aberrant Nuclear Localization and Gene Mutation of β-catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors that Form MorulesLaboratory Investigation, 2002
- IGF-II induces rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transitionOncogene, 2001
- Carcinosarcomas of the LungThe American Journal of Surgical Pathology, 1999
- Pulmonary Adenocarcinomas of the Fetal Lung TypeThe American Journal of Surgical Pathology, 1998
- Pulmonary blastoma with argyrophil cells and lacking sarcomatous features (pulmonary endodermal tumor resembling fetal lung)The American Journal of Surgical Pathology, 1982
- Pulmonary blastomasThe Journal of Pathology and Bacteriology, 1961
- "Embryoma of Lung"Thorax, 1952